Concepedia

1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3

Mark Sulkowski, David Gardiner, E. Läwitz, Federico Hinestrosa, Daniel Nelson, Paul J. Thuluvath, M. Rodríguez‐Torres, Anna S. Lok, Howard Schwartz, K. Rajender Reddy,

Journal of Hepatology · 2012 · 80 citations · 0 references

DOI

Concepts